1. National Institute for Health and Care Excellence. Prostate cancer: Diagnosis and Management. NICE clinical guideline CG175 developed by the National Collaborating Centre for Cancer. 2014. https://www.nice.org.uk/guidance/cg175. .
2. Anandadas, C N, Clark, N W, Davidson, S E et al. Early prostate cancer—which treatment do men prefer and why? BJU Int 2011; 107 (11): 1762–1768.
3. Bauman, G, Rumble, R B, Chen, J, Loblaw, A, Warde, P. Intensity-modulated radiotherapy in the treatment of prostate cancer. Clin Oncol 2012; 24 (7): 461–473.
5. Ferlay, J, Soerjomataram, I, Dikshit, R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 (5): E359–E386.
6. ACORRN Research Radiographer Working Party, Russell, W, McNair, HA et al. Gap analysis of role definition and training needs for Therapeutic Research Radiographers in the UK. Br J Radiol 2007; 80: 693–701.
10. Lee, L. The role of the “on treatment” review radiographer: what are the requirements? J Radiother Pract 2008; 7: 113–131.
11. Colyer, H. The role of the radiotherapy treatment review radiographer. Radiography 2000; 6: 253–260.
12. Ellis, T, Ashmore, L, Bray, D. Multidisciplinary radiographer-led review clinics—an example of implementation. J Radiother Pract 2006; 5: 87–95.
13. Morote, J, Maldonado, X, Morales-Bárrera, R. Prostate cancer. Clinical Medicine 2016; 146 (3): 121–127.
14. Kalbasi, A, Li, J, Berman, A T et al. Dose-escalated irradiation and overall survival in men with nonmetastatic prostate cancer. JAMA Oncol. 2015; 1: 897–906.
15. Kim, MM, Hoffman, KE, Levy, LB et al. Improvement in prostate cancer survival over time: a 20-year analysis. Cancer J 2012; 18 (1): 1–8.
16. Coyne, K, Zhou, Z, Thompson, C, Versi, E. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 2003; 92 (7): 731–735.
17. Schaake, W, Wiegman, M E, de Groot, M et al. The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients. Radiother Oncol 2014; 110: 284–290.
18. Widmark, A, Klepp, O, Solberg, A et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009; 373: 301–308.
19. Kumar, R J, Barqawi, A, Crawford, E D. Adverse events associated with hormonal therapy for prostate cancer. Rev Urol 2005; 7 (Suppl 5): S47–S443.
20. Boberg, EW, Gustafson, D H, Hawkins, R P et al. Assessing the unmet information, support and care delivery needs of men with prostate cancer. Patient Educ Couns 2003; 49 (3): 233–242.
21. Ormerod, AM, Jessop, AJ. An evaluation of support of patients with prostate cancer during and beyond radiotherapy treatment. A local perspective on future provision. J Radiother Pract 2015; 14 (4): 370–377.
22. Evans, C M, Burnet, N G, Hall, E, Huddart, R A, Nutting, C M, Coles, C E. The Radiotherapy clinical trial research landscape in the UK between 2004 and 2013: A cross-sectional analysis. Clin Oncol 2015; 27 (9): 491–494.
23. Dearnaley, D, Syndikus, I, Mossop, H et al. 8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP trial investigators group. Eur J Cancer 2015; 51 (3): S712.
24. Van Dongen, AJ. Good clinical practice, a transparent way of life. A review. Comput Med Imaging Graph 2001; 25 (2): 213–216.
25. White, P, McKay, JC. Guidelines and legal requirements, which inform role expansion in radiography. Radiography 2002; 8 (2): 71–78.
26. Høyer, M, Muren, PL, Glimelius, B. The evolution of radiotherapy techniques in the management of prostate cancer. Acta Oncologica 2015; 54 (6): 821–824.
27. Chin, S, Hayden, AJ, Gebski, V, Cross, S, Turner, S L. Long term patient reported urinary function following external beam radiotherapy for prostate cancer. Clin Oncol 2017; 29 (7): 421–428.
28. Crowther, K, Shepherd, PH, Shiels, P, Jain, S, Mitchell, D. A pilot study of patient reported outcomes evaluating treatment related symptoms and quality of life for men receiving high dose rate brAchytherapy combined with hypo-fractionated radiotherapy or hypo-fractioNated radiotherapy alone for the treatment of localised prostate cancer. tipsRO. 2018; .
30. Probst, H, Griffiths, S. Job satisfaction of therapy radiographers in the UK: results of a phase I qualitative study. Radiography 2009; 15 (2): 146–157.